Kapila K. Anand - 29 Jan 2021 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Director
Signature
/s/ Jinee L. Majors, as Attorney-in-Fact for Kapila K. Anand
Issuer symbol
ELAN
Transactions as of
29 Jan 2021
Transactions value $
$25,657
Form type
4
Date filed
03 Aug 2021, 16:39
Next filing
09 Jun 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Deferred Stock Units Award $3.67K +126 $29.03 126 29 Jan 2021 Common Stock 126 Direct F1, F2, F3
transaction ELAN Deferred Stock Units Award $3.67K +112 +88.34% $32.86 238 26 Feb 2021 Common Stock 112 Direct F1, F2, F4
transaction ELAN Deferred Stock Units Award $3.67K +125 +52.34% $29.45 362 31 Mar 2021 Common Stock 125 Direct F1, F2, F5
transaction ELAN Deferred Stock Units Award $3.67K +116 +31.91% $31.71 478 30 Apr 2021 Common Stock 116 Direct F1, F2, F6
transaction ELAN Deferred Stock Units Award $3.67K +102 +21.32% $35.98 580 28 May 2021 Common Stock 102 Direct F1, F2, F7
transaction ELAN Deferred Stock Units Award $3.67K +106 +18.23% $34.69 686 30 Jun 2021 Common Stock 106 Direct F1, F2, F8
transaction ELAN Deferred Stock Units Award $3.66K +101 +14.66% $36.37 786 30 Jul 2021 Common Stock 101 Direct F1, F2, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Ms. Anand elected to defer her director cash retainer fees pursuant to the Company's Directors' Deferral Plan (the "Plan") and such deferred fees were credited to the Elanco Deferred Stock Account under the Plan. Each Deferred Stock Unit is the economic equivalent of one share of Elanco common stock.
F2 The Deferred Stock Units will be settled in stock upon the reporting person's separation of service from the Company's Board of Directors pursuant to the Plan.
F3 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.03 on January 29, 2021.
F4 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $32.86 on February 26, 2021.
F5 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $29.45 on March 31, 2021.
F6 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $31.71 on April 30, 2021.
F7 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $35.98 on May 28, 2021.
F8 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $34.69 on June 30, 2021.
F9 The number of Deferred Stock Units issued is the amount of cash compensation deferred divided by the closing price of a share of Elanco common stock on the grant date, which was $36.37 on July 30, 2021.

Remarks:

EXHIBIT LIST - Exhibit 24 - Power of Attorney for Kapila K. Anand.